EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Keratin‐positive giant cell‐rich tumors of soft tissue with HMGA2::NCOR2 fusions

Maximillian A Weigelt iD, Elizabeth M Azzato, Gabriel K Habermehl, Steven D Billings iD, Jennifer S Ko iD, Karen J Fritchie

Journal of Cutaneous Pathology · 2023

DOI: 10.1111/cup.14497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, 2023. Verfasst von Maximillian A Weigelt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Giant Cell Tumors, Soft Tissue Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Giant cell tumor of soft tissue (GCT‐ST) is a rare soft tissue neoplasm that is morphologically similar to but genetically distinct from giant cell tumor of bone. A novel keratin‐positive GCT‐ST (KPGCT‐ST) harboring HMGA2::NCOR2 fusions was recently discovered. Fewer than 30 cases have been described; herein is reported an additional seven.

Methods

Cases diagnosed as GCT‐ST were retrieved from institutional archives and consultation files. The histopathologic characteristics were assessed, and the electronic medical record was reviewed.

Results

Seven tumors were identified in six women and one man with a median age of 23 years. All patients underwent excision; no recurrences or metastases were noted during a median follow‐up period of 7 months. Histopathologically, the tumors were characterized by a multinodular proliferation of keratin‐positive mononuclear cells with evenly admixed osteoclast‐like giant cells and absent neoplastic bone. A fibrous capsule with lymphoid cuffing was frequently seen. Foamy macrophages, inflammation, hemorrhage, and hemosiderin were variably present. The HMGA2::NCOR2 fusion was detected in all cases.

Conclusions

Our findings support previously reported hypotheses that KPGCT‐ST is a spectrum of the same entity as the recently described xanthogranulomatous epithelial tumor. Although follow‐up data are limited, to date, KPGCT‐ST appears to follow an indolent course.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell TumorsSoft Tissue NeoplasmsMaleHumansFemaleYoung AdultAdultKeratinsDiagnosis, DifferentialGiant CellsNuclear Receptor Co-Repressor 2

Stichwörter der Autor:innen

HMGA2giant cell tumorkeratinxanthogranulomatous epithelial tumor

Substanzen

KeratinsNCOR2 protein, humanNuclear Receptor Co-Repressor 2

Autor:innen und Institutionen

  • Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Pathology, Summit Pathology, Loveland, Colorado, USA.

ORCID-Profile: Maximillian A Weigelt, Steven D Billings, Jennifer S Ko

Zitieren

APA

Weigelt, M. A., Azzato, E. M., Habermehl, G. K., Billings, S. D., Ko, J. S., & Fritchie, K. J. (2023). Keratin‐positive giant cell‐rich tumors of soft tissue with HMGA2::NCOR2 fusions. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14497

Vancouver

Weigelt MA, Azzato EM, Habermehl GK, Billings SD, Ko JS, Fritchie KJ. Keratin‐positive giant cell‐rich tumors of soft tissue with HMGA2::NCOR2 fusions. Journal of Cutaneous Pathology. 2023. doi:10.1111/cup.14497

BibTeX
@article{Weigelt2023,
  author = {Weigelt, Maximillian A and Azzato, Elizabeth M and Habermehl, Gabriel K and Billings, Steven D and Ko, Jennifer S and Fritchie, Karen J},
  title = {Keratin‐positive giant cell‐rich tumors of soft tissue with HMGA2::NCOR2 fusions},
  journal = {Journal of Cutaneous Pathology},
  year = {2023},
  doi = {10.1111/cup.14497}
}
Kostenlos starten →